4th Quarter - Amendment

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

Firm
Client
Income
—
Expenses
$1,670,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2026 $1,640,000 Replaced
4th Quarter - Amendment (this page) Apr 20, 2026 $1,670,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to prior authorization.

LobbyistCovered position, as disclosed
COURTNEY LAWRENCE —
KARA SMITH —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Health Issues HCR

S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) including in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA); Issues relating to implementation of the No Surprises Act.

LobbyistCovered position, as disclosed
KATHRYN GALLAGHER —
CHRISTOPHER HARTMANN —
COURTNEY LAWRENCE —
JULIEN MITCHELL RELFE —
KARA SMITH —
KRISTINA KAYE WEGER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 864 (119th), H.R. 247 (119th)

Defense DEF

H.R. 3838/S. 2296 Pharmacy issues related to the National Defense Authorization Act, FY2026.

LobbyistCovered position, as disclosed
KATHRYN GALLAGHER —
CHRISTOPHER HARTMANN —
COURTNEY LAWRENCE —
JULIEN MITCHELL RELFE —
KARA SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2296 (119th), H.R. 3838 (119th)

Pharmacy PHA

"S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act." Issues related to the specialty drug market. Issues related to transparency.

LobbyistCovered position, as disclosed
KATHRYN GALLAGHER —
CHRISTOPHER HARTMANN —
COURTNEY LAWRENCE —
JULIEN MITCHELL RELFE —
KARA SMITH —
KRISTINA KAYE WEGER —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP)

Bills named: H.R. 5378 (119th), S. 526 (119th), S. 1339 (119th), H.R. 2214 (119th), S. 1542 (119th)

Labor Issues/Antitrust/Workplace LBR

Issues related to competition in the health care marketplace.

LobbyistCovered position, as disclosed
KATHRYN GALLAGHER —
CHRISTOPHER HARTMANN —
COURTNEY LAWRENCE —
JULIEN MITCHELL RELFE —
KARA SMITH —
KRISTINA KAYE WEGER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.